Rat Anti-CNTN3 Recombinant Antibody (CBYY-C0314) (V2LY-1206-LY540)

Korotkov, A., Luinenburg, M. J., Romagnolo, A., Zimmer, T. S., van Scheppingen, J., Bongaarts, A., ... & Aronica, E. (2022). Down-regulation of the brain-specific cell-adhesion molecule contactin-3 in tuberous sclerosis complex during the early postnatal period. Journal of neurodevelopmental disorders, 14(1), 1-16.

Mamoor, S. (2021). CNTN3 is differentially expressed in lymph node metastasis in human breast cancer.

Zhou, J., Xie, Z., Cui, P., Su, Q., Zhang, Y., Luo, L., ... & Huang, J. (2020). SLC1A1, SLC16A9, and CNTN3 are potential biomarkers for the occurrence of colorectal cancer. BioMed Research International, 2020.

Zhu, Y. F., Guo, Y. B., Zhang, H. Y., Yang, P., Wei, D. F., Zhang, T. T., ... & Liu, L. (2019). Prognostic significance of contactin 3 expression and associated genes in glioblastoma multiforme. Oncology Letters, 18(2), 1863-1871.

Peng, X., Williams, J., Smallwood, P. M., & Nathans, J. (2019). Defining the binding interface of Amyloid Precursor Protein (APP) and Contactin3 (CNTN3) by site-directed mutagenesis. Plos one, 14(7), e0219384.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols